Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma

BACKGROUND: Effective treatments for cholangiocarcinoma (CCA) are still lacking. There are promising results of checkpoint inhibitor programmed cell death ligand-1 (PD-L1) activities in early phase trials. This study aimed to investigate the expression of PD-L1 and its relation to possible treatment...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Asian Pac J Cancer Prev
Κύριοι συγγραφείς: Sangkhamanon, Sakkarn, Jongpairat, Piangpen, Sookprasert, Aumkhae, Wirasorn, Kosin, Titapun, Attapol, Pugkhem, Ake, Ungareevittaya, Piti, Chindaprasirt, Jarin
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: West Asia Organization for Cancer Prevention 2017
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373788/
https://ncbi.nlm.nih.gov/pubmed/28670887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.6.1671
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια